There aren’t any specific age-related concerns for women aged over 40 by using the progestogen-only
Depot medroxyprogesterone acetate (DMPA) are related to a reduction in bone tissue nutrient thickness (BMD) in females of every age group. 1 Reassuringly, scientific studies evaluating girls over 40 who use DMPA show that although users undertaking an initial decrease in BMD with need, it is not repeated or worsened by menopausal. 1 female over 40 with extra risk facets for osteoporosis are advised to start thinking about alternate means.